Cog-VACCINE: Cognitive Training in Patients With Vascular Cognitive Impairment, no Dementia (NCT02640716) | Clinical Trial Compass
CompletedNot Applicable
Cog-VACCINE: Cognitive Training in Patients With Vascular Cognitive Impairment, no Dementia
China60 participantsStarted 2015-10
Plain-language summary
This study evaluates the efficacy and mechanism of internet-based cognitive training in patients with subcortical VCIND. Half of participants will receive multi-domain adaptive internet-based training program, while the other half will receive a fixed, primary difficulty level task.
Who can participate
Age range50 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Literate Han Chinese, aged 50-78 years, with a consistent caregiver who accompanies the subject at least 4 days a week;
* Complaint and/or informant report of cognitive impairment involving memory and/or other cognitive domains lasting for at least 3 months;
* Neither normal nor demented according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, with a clinical dementia rating (CDR) ≥ 0.5 on at least one domain and global score ≤ 0.5; a Mini-Mental State Examination (MMSE) score ≥ 20 (primary school) or ≥ 24 (junior school or above);
* Normal or slightly impaired activities of daily living as defined by a total score of ≤ 1.5 on the three functional CDR domains (home and hobbies, community affairs, and personal care).
The MRI entry criteria are as follows:
* Multiple (≥ 3) supratentorial subcortical small infarcts (3-20 mm in diameter), with/without white matter lesions (WML) of any degree; or moderate to severe WML (score ≥ 2 according to the Fazekas rating scale) with/without small infarct;
* Absence of cortical and watershed infarcts, hemorrhages, hydrocephalus, and WMLs with specific causes (e.g., multiple sclerosis);
* No hippocampal or entorhinal cortex atrophy (score 0 according to the medial temporal lobe atrophy scale of Scheltens).
Exclusion Criteria:
* severe aphasia, physical disabilities, or any other factor that may preclude completion of neuropsychological testing;
* disorders other than su…
What they're measuring
1
Estimated Mean Change of the Montreal Cognitive Assessment (MoCA)
Timeframe: Baseline and 7 weeks
2
Estimated Mean Change of the Trail Making Test (TMT) B-A